ResearchMoz

Global Private Cloud Market 2012-2016

Technavio
Published Date » 2012-12-31
No. Of Pages » 41
   
 TechNavio's analysts forecast the Global Private Cloud market to grow at a CAGR of 8.98 percent over the period 2012-2016. One of the key factors contributing to this market growth is the reduced costs of the cloud approach. The Global Private Cloud market has also been witnessing the growing adoption of hybrid cloud computing models. However, the high initial costs of private cloud adoption could pose a challenge to the growth of this market. 
   
 TechNavio's report, the Global Private Cloud Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Private Cloud market landscape and its growth prospects in the coming years. The report also...
Table of Contents: 

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Key Offerings

4. Market Landscape
4.1 Market Size and Forecast
4.2 Five Forces Analysis

5. End-user Segmentation

6. Geographical Segmentation

7. Vendor Landscape
7.1 Competitive Landscape of Vendors
7.2 Major Acquisitions
7.3 Key Developments

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis
14.1 Amazon.com Inc.
Business Overview
Key Information
SWOT Analysis
14.2 Hewlett-Packard Co.
Business Overview
Key Information
SWOT Analysis
14.3 IBM Corp.
Business Overview
Key Information
SWOT Analysis
14.4 Microsoft Corp.
Business Overview
Key Information
SWOT Analysis
14.5 VMware Inc.
Business Overview
Key Information
SWOT Analysis

15. Other Reports in this Series

List of Tables


List of Figures


Exhibit 1: Global Private Cloud Market 2012-2016 (US$ billion)
Exhibit 2: Global Private Cloud Market by End-user Segmentation 2012
Exhibit 3: Global Private Cloud Market by Geographical Segmentation 2012
Exhibit 4: Global Private Cloud Market by Key Vendor Capabilities 2012

Upcoming Reports:

Greece: market of fresh and chilled goat, lamb and sheep meat
By - Williams and Marshal Strategy
ece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Greece in 2008-2012 and a forecast for its development in...
Poland: plums and sloes market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the plums and sloes market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the plums and sloes market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Market - Global Forecast, Market Share, Size, Growth and Industry Analysis, 2012 - 2018
By - Transparency Market Research
Nanoscience or nanotechnology is the study of management of materials at molecular or atomic scale on different applications. The market for nanoparticles in drug technology holds prime share in the global pharmaceuticals market. Applications of nanotechnology can be classified into nanomedicine, chemicals and cosmetics, materials, food technology, energy, military, electronics, agriculture and others. Use of nanoparticles in pharmaceutical technology is mainly driven by growth in demand for personalized medicine. This market is classified according to applications such as...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...